BIRC5 and neoplasm: In addition, they also found the positive relationships between the high‐risk group and the high frequency of TP53 inactivation mutations, high expression of tumour biomarkers (KRT19, EpCAM and BIRC5) and the activated pro‐tumour AKT and Wnt pathway.339